Grigorios Siokas Buys Shares of Cosmos Health Inc. $COSM

Key Points

  • Grigorios Siokas bought 218,447 shares of Cosmos Health Inc. ($COSM) worth $45,873.87.
  • $COSM last traded around $0.21.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Grigorios Siokas, Chief Executive Officer at Cosmos Health Inc. ($COSM), bought 218,447 shares at an average price of $0.21, for a total transaction of $45,873.87. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.

Cosmos Health Inc. Stock Down 6.5%

Shares of Cosmos Health Inc. ($COSM) traded around $0.21 on Saturday, down 6.5% for the day.

Last price$0.21
Market cap$24.45M
Forward P/E3.47
Beta4.17
52-week low$0.16
52-week high$1.32
50-day MA$0.22
200-day MA$0.36
Current ratio1.05
Quick ratio0.67
Debt-to-equity0.77

Cosmos Health Inc. Earnings

EPS (ttm)-$0.67
Revenue (ttm)$73.73M
Revenue growth28.80%
Net margin-33.08%
Return on equity-104%
Next earningsApr 16, 2025

Analysts Set New Price Targets

ConsensusStrong Buy
Average target$4.50
High target$4.50
Low target$4.50
Analysts covering1

About Cosmos Health Inc.

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.

ExchangeNasdaqCM
SectorHealthcare
IndustryMedical Distribution
HeadquartersThessaloniki, Greece
CEOMr. Grigorios Siokas
Employees163

Get Cosmos Health Inc. alerts

New 13F filings, insider trades, and analyst moves on $COSM, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.